• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

杏仁核中磷酸二酯酶-2 活性的降低导致小鼠行为出现焦虑样效应。

Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice.

机构信息

1 Department of Pharmacy, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.

2 Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, the State University of New York, Buffalo, NY, USA.

出版信息

J Psychopharmacol. 2019 May;33(5):568-576. doi: 10.1177/0269881119832753. Epub 2019 Mar 5.

DOI:10.1177/0269881119832753
PMID:30835157
Abstract

BACKGROUND

Phosphodiesterase-2 (PDE2) is a cyclic nucleotide phosphodiesterase and is highly expressed in the amygdala, which suggests its important role in anxiety-like behavior.

AIMS

The present study examined whether reduced PDE2A expression in the central nucleus of the amygdala (CeA) produces anxiolytic-like effects in mice.

METHODS

PDE2A knockdown in amygdaloid (AR5) cells or the CeA was established using a lentiviral vector-based siRNA system. The anxiety-like behaviors were detected by the elevated plus maze (EPM) and hole-board tests in mice. The related proteins involved in cAMP/cGMP-dependent signaling, such as specific marker VASP, CREB and BDNF were detected by immunoblot analysis.

RESULTS

PDE2A inhibition in AR-5 cells resulted in increases in cAMP/cGMP-related pVASP and pCREB. Behavioral tests showed that PDE2A knockdown in the CeA induced anxiolytic-like effects as evidenced by the increases in percentages of open-arm entries and time spent in the open arms in the EPM test, and the increases in head dips and time spent in head dipping in the hole-board test. However, these anxiolytic-like effects were antagonized by pre-treatment of soluble guanylyl cyclase inhibitor ODQ or adenylate cyclase inhibitor SQ. Furthermore, PDE2A knockdown significantly increased pVASP, pCREB and decreased BDNF expression in the amygdala. Pre-intra-CeA of ODQ or SQ reversed or partially prevented the effects of PDE2A knockdown on these proteins.

CONCLUSIONS

The results suggest that PDE2A plays a crucial role in the regulation of anxiety by the cGMP/cAMP-dependent pVASP-pCREB-BDNF signaling pathway.

摘要

背景

磷酸二酯酶-2(PDE2)是一种环核苷酸磷酸二酯酶,在杏仁核中高度表达,这表明它在焦虑样行为中具有重要作用。

目的

本研究旨在探讨杏仁核中央核(CeA)中 PDE2A 表达减少是否会产生类似焦虑的作用。

方法

采用基于慢病毒载体的 siRNA 系统建立杏仁核(AR5)细胞或 CeA 中的 PDE2A 敲低。通过高架十字迷宫(EPM)和洞板试验检测小鼠的焦虑样行为。通过免疫印迹分析检测涉及 cAMP/cGMP 依赖性信号的相关蛋白,如特异性标志物 VASP、CREB 和 BDNF。

结果

AR-5 细胞中 PDE2A 抑制导致 cAMP/cGMP 相关 pVASP 和 pCREB 增加。行为测试显示,CeA 中的 PDE2A 敲低诱导了类似焦虑的作用,表现为 EPM 测试中开放臂进入次数和开放臂时间的百分比增加,以及洞板测试中头部浸入次数和头部浸入时间的增加。然而,这些类似焦虑的作用被可溶性鸟苷酸环化酶抑制剂 ODQ 或腺苷酸环化酶抑制剂 SQ 的预处理所拮抗。此外,PDE2A 敲低显著增加了杏仁核中的 pVASP、pCREB,并降低了 BDNF 的表达。CeA 内预先注射 ODQ 或 SQ 逆转或部分阻止了 PDE2A 敲低对这些蛋白的影响。

结论

结果表明,PDE2A 通过 cGMP/cAMP 依赖性 pVASP-pCREB-BDNF 信号通路在焦虑的调节中起着关键作用。

相似文献

1
Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice.杏仁核中磷酸二酯酶-2 活性的降低导致小鼠行为出现焦虑样效应。
J Psychopharmacol. 2019 May;33(5):568-576. doi: 10.1177/0269881119832753. Epub 2019 Mar 5.
2
Inhibition of phosphodiesterase 2 reverses gp91phox oxidase-mediated depression- and anxiety-like behavior.抑制磷酸二酯酶 2 可逆转 gp91phox 氧化酶介导的抑郁和焦虑样行为。
Neuropharmacology. 2018 Dec;143:176-185. doi: 10.1016/j.neuropharm.2018.09.039. Epub 2018 Sep 27.
3
Phosphodiesterase-2 inhibitor reverses post-traumatic stress induced fear memory deficits and behavioral changes via cAMP/cGMP pathway.磷酸二酯酶-2 抑制剂通过 cAMP/cGMP 通路逆转创伤后应激引起的恐惧记忆缺陷和行为改变。
Eur J Pharmacol. 2021 Jan 15;891:173768. doi: 10.1016/j.ejphar.2020.173768. Epub 2020 Dec 1.
4
Characterization of 2 Novel Phosphodiesterase 2 Inhibitors Hcyb1 and PF-05180999 on Depression- and Anxiety-Like Behavior.研究新型磷酸二酯酶 2 抑制剂 Hcyb1 和 PF-05180999 对抑郁和焦虑样行为的作用特征。
Int J Neuropsychopharmacol. 2023 Jun 23;26(6):415-425. doi: 10.1093/ijnp/pyad020.
5
Inhibition of Phosphodiesterase 2 Ameliorates Post-Traumatic Stress-Induced Alcohol Intake Disorder by Regulating cAMP/cGMP Signaling.抑制磷酸二酯酶 2 通过调节 cAMP/cGMP 信号转导改善创伤后应激诱导的酒精摄入障碍。
Int J Neuropsychopharmacol. 2022 Nov 17;25(11):936-945. doi: 10.1093/ijnp/pyac064.
6
Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice.通过抑制小鼠磷酸二酯酶-2逆转氧化应激诱导的焦虑
J Pharmacol Exp Ther. 2008 Aug;326(2):369-79. doi: 10.1124/jpet.108.137208. Epub 2008 May 2.
7
The antidepressant- and anxiolytic-like effects of resveratrol: Involvement of phosphodiesterase-4D inhibition.白藜芦醇的抗抑郁和抗焦虑样作用:涉及磷酸二酯酶-4D 抑制。
Neuropharmacology. 2019 Jul 15;153:20-31. doi: 10.1016/j.neuropharm.2019.04.022. Epub 2019 Apr 24.
8
Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway.磷酸二酯酶-2 抑制剂通过 cGMP/PKG 依赖性途径逆转皮质酮诱导的神经毒性和相关行为改变。
Int J Neuropsychopharmacol. 2013 May;16(4):835-47. doi: 10.1017/S146114571200065X. Epub 2012 Jul 31.
9
Protective effects of phosphodiesterase 2 inhibitor on depression- and anxiety-like behaviors: involvement of antioxidant and anti-apoptotic mechanisms.磷酸二酯酶2抑制剂对抑郁样和焦虑样行为的保护作用:抗氧化和抗凋亡机制的参与
Behav Brain Res. 2014 Jul 15;268:150-158. doi: 10.1016/j.bbr.2014.03.042. Epub 2014 Mar 30.
10
Phosphodiesterase 2 inhibitor Hcyb1 reverses corticosterone-induced neurotoxicity and depression-like behavior.磷酸二酯酶 2 抑制剂 Hcyb1 逆转皮质酮诱导的神经毒性和抑郁样行为。
Psychopharmacology (Berl). 2020 Nov;237(11):3215-3224. doi: 10.1007/s00213-019-05401-1. Epub 2020 Sep 14.

引用本文的文献

1
Longevity, enhanced memory, and altered density of dendritic spines in hippocampal CA3 and dentate gyrus after hemizygous deletion of Pde2a in mice.小鼠半合子缺失Pde2a后,其寿命延长、记忆力增强,海马CA3区和齿状回的树突棘密度改变。
Neuropsychopharmacology. 2025 Apr;50(5):808-817. doi: 10.1038/s41386-024-02031-w. Epub 2024 Nov 27.
2
Phosphodiesterase inhibitors in psychiatric disorders.精神障碍中的磷酸二酯酶抑制剂。
Psychopharmacology (Berl). 2023 Jun;240(6):1201-1219. doi: 10.1007/s00213-023-06361-3. Epub 2023 Apr 15.
3
PDE2A Inhibition Enhances Axonal Sprouting, Functional Connectivity, and Recovery after Stroke.
PDE2A 抑制增强卒中后轴突发芽、功能连接和恢复。
J Neurosci. 2022 Nov 2;42(44):8225-8236. doi: 10.1523/JNEUROSCI.0730-22.2022. Epub 2022 Sep 26.
4
Phenotypic Trade-Offs: Deciphering the Impact of Neurodiversity on Drug Development in Fragile X Syndrome.表型权衡:解读神经多样性对脆性X综合征药物开发的影响。
Front Psychiatry. 2021 Oct 18;12:730987. doi: 10.3389/fpsyt.2021.730987. eCollection 2021.